Famypra Update - June 2015

An article in the Sunday Business Post by journalist Susan Mitchell reports that a HSE representative said 'significant progress has been made in commercial discussions with Biogen' (the makers of the multiple sclerosis (MS) drug Famypra)

Ava Battles, MS Ireland Chief Executive, commented that 'people with MS and their families would be delighted to hear that a breakthrough looks imminent. It will be a huge relief for people who are funding it themselves as well as those who cannot afford it and have been doing without, even though it would benefit them'.

MS Ireland is still awaiting news and will update you as soon as there are further developments.

Further information

Top